Hypera S.A. (HYPMY) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Brazil, listed on OTC Markets OTCID. Market cap 3.76B USD. 52-week range 3.71 to 5.77 USD. Trailing P/E 10.7. Data as of 2026-10-09.
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Coristina, APRACUR, and Fluviral brands. It offers antihistamines products under Alektos, Histamin, ...